Aldosterone
In clinical developmentAlso known as (+)-aldosterone, Aldosterona, 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al, 11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al+1 more
(+)-aldosterone, Aldosterona, 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al, 11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al, Aldosteronum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
Anorexia nervosa and adrenal hormones: a systematic review and meta-analysis.
The renin-angiotensin-aldosterone system and its suppression.
Aldosterone and Glucose Homeostasis
Studies on Aldosterone and Vascular Function
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Aldosterone and Glucose Homeostasis
Studies on Aldosterone and Vascular Function
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes4
Journals, researchers & institutions
- Circulation1
- European journal of endocrinology1
- Journal of veterinary internal medicine1
- Agharazii M1
- Ames MK1
- Atkins CE1
- Brown JM1
- Crean AM1
- Fazeli PK1
- Goupil R1
- Hametner B1
- Brigham and Women's Hospital1
- Center for Adrenal Disorders1
- Center for Health & Bioresources1
- CHU de Québec-Université Laval1
- Chulalongkorn University and Excellence Center in Diabetes1
- Cleveland Clinic1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Aldosterone in the shared literature.
Studied across the same disease area as Aldosterone in the shared literature.
Studied across the same disease area as Aldosterone in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials